CRWE, Crown Equity Holdings Inc., CRWE.OB
Advertising during a sluggish economy clearly creates a competitive advantage, with a majority of executives agreeing that seeing a company advertise during slower times makes them feel more positive about the company’s commitment to its products and services. But perhaps most important is staying at the top of potential investors’ minds when decisions are made.
CRWE is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.
CRWE recently reported its financial results for the nine month period ending September 30, 2010.
Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009. CRWE incurred an operating loss of $54,527 for the nine months ending September 30, 2010 compared to an operating loss of $36,923 during the same period in 2009. Net loss of $343,049 for the nine months ending September 30, 2010 compared to a net loss of $29,379 for the same period in 2009. The net loss in 2010 was attributed mostly to an unrealized loss of $307,544 on securities held by CRWE.
More about CRWE at www.crownequityholdings.com.
Telestone Technologies Corp. (Nasdaq:TSTC) recently reported that it has retained CCG Investor Relations ("CCG") to design and execute its investor relations campaign. Telestone has historically developed network-access equipment for the wireless communications market in China, offering equipment, project design, and after-sales services customized to meet customer requirements. The Company has developed close business relationships with the three major Chinese wireless carriers--China Mobile, China Unicom, China Telecom (the "Big 3")--as its main customers. Since 2006, Telestone has focused on expanding its international presence.
Telestone is a leader and innovator in wireless local-access network technologies and solutions. Telestone has installed radio-frequency (NYSE:RF)-based 1G and 2G systems throughout China for its leading telecommunications companies.The Company has approximately 1,200 employees.
Monotype Imaging Holdings Inc. (Nasdaq:TYPE) recently reported that in association with its Dec. 8, 2010 acquisition of Ascender Corp., and in compliance with Nasdaq Marketplace Rule 5635(c), Monotype Imaging has granted equity awards as inducement awards to employees of Ascender who are now joining Monotype Imaging. Under the terms of the agreement, Monotype Imaging has purchased Ascender Corp. for $10.2 million, net of acquired assets, split between cash ($7.0 million) and shares of restricted common stock ($3.2 million). Additional shares of restricted common stock and non-qualified stock options with an aggregate value of $1.8 million will be provided to certain employees of Ascender in connection with their employment by Monotype Imaging.
Monotype Imaging combines technology with design to help the world communicate. Based in Woburn, Mass. with offices in the U.S., Europe and Asia, Monotype Imaging brings text imaging and graphical user interface capabilities to consumer electronics devices such as laser printers, copiers, mobile phones, digital televisions, set-top boxes, navigation devices, digital cameras, e-book readers and consumer appliances.
Res-Care Inc. (Nasdaq:RSCR) recently reported that it plans to raise up to $200 million through a private placement of senior notes due 2018 ("New Notes"), subject to market and other customary conditions. The Company's domestic subsidiaries will fully and unconditionally guarantee the New Notes. The Company intends to use the net proceeds from the proposed placement to repurchase and retire the $150 million aggregate principal amount of its 7.75% Senior Notes Due 2013, to fund the second-step share exchange through which an affiliate of Onex Partners III, L.P. will complete the acquisition of all of the equity shares of ResCare, and for general corporate purposes. Completion of the placement of New Notes is subject to market conditions and is not a condition to closing the second-step share exchange.
Res-Care, Inc., a human service company, provides residential, therapeutic, job training, and educational support services in the United States and Canada. Res-Care, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky. As of November 15, 2010, Res-Care Inc. was taken private.
PWRM, Power3 Medical Products Inc, PWRM.OB
Alzheimer's disease isn't an ordinary part of getting older, even though greatest known risk factor is increasing age, along with the largest part of people today with Alzheimer's tend to be 65 and older. But Alzheimer's is not just a sickness of old age. Up to 5 % of people with the sickness currently have early-onset Alzheimer's (also referred to as younger-onset), which frequently appears when ever someone is within his or her 40s or 50s.
Soon after skin cancer, cancer of the breast is easily the most widespread cancers recognized in females in the united states. But breast cancer rates now have fallen in recent times, even so medical professionals are not certain the key reason why. Even now, for numerous women of all ages, breast cancer could be the condition they will fear most.
Parkinson's disease is really a problem that affects nerve cells, or neurons, inside of a section of the brain of which controls muscle motions. In Parkinson's, nerves which make an important chemical called dopamine die or do not work properly. Dopamine generally delivers impulses that assist synchronize a person's activities.
PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, PWRM has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
More about PWRM at www.Power3Medical.com
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).